Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
about
Molecular functions of thyroid hormones and their clinical significance in liver-related diseasesThe chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxisThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingSelective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammationPotent antitumor activity of a urokinase-activated engineered anthrax toxin.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Anthrax toxin: structures, functions and tumour targeting.Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.uPA deficiency exacerbates muscular dystrophy in MDX mice.Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.A novel autologous cell-based therapy to promote diabetic wound healing.A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cellsInactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor.Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.Proteases as prognostic markers in human and canine cancers.Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation.MHJ_0461 is a multifunctional leucine aminopeptidase on the surface of Mycoplasma hyopneumoniae.The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis.Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.MEKK1 is required for inducible urokinase-type plasminogen activator expression.Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin.Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
P2860
Q21284820-64B7BA43-9966-4F5D-A43A-952E4A3B3A3DQ22253459-B092B0E2-2CBF-476E-92DF-176A2882B218Q28257803-D5C20D93-1A73-4AD8-9470-C2464E1EE0D5Q30496585-D405B09E-C526-4E2B-AB3C-4AF276EFC0E7Q34470439-F7851005-CC09-4EEB-A30E-4D0DB7EE634DQ34606581-43236238-AA51-4B78-8000-CE114DF6670CQ35184740-C0365C58-25F2-41B3-9D30-EB29EAC51C4CQ35221823-FFEB294B-584E-4600-92D9-6ED58BDE35ACQ36086826-50D528CC-724E-42E9-9D97-B99E2DA518DAQ36119288-C8C0BCFD-544E-48DD-AD80-649283C28321Q36201781-7855D189-A7AC-4FAF-BC70-D722DC0CAE7DQ36301623-7B294015-834B-4B3E-9745-BA5235FCE1F1Q36651337-1371076C-D45D-498F-B80B-7D129885A130Q36777944-F37861CE-AFB0-40E7-814D-7DAB536E5336Q37132905-68494446-2284-4560-8789-483686A3A409Q37335608-E8C845E8-A677-4280-B189-482F30945F06Q38293889-045B877A-B10B-41CB-A1FF-D36B74AB2EB7Q38328240-124A8590-C02C-4074-8770-2196330FBBA5Q38584976-891D98D0-D97E-4604-AC0B-16B027F270A6Q38823174-C9BEECA8-66B1-4B41-9649-9823CB9051F1Q39250854-43757A1F-BD77-4BB9-9A13-07B9C8C4BEC7Q40637766-2901157C-E828-43A8-A326-D68433DBE2A9Q40735093-58DD918C-F640-4BB3-87AB-BDB4D42107FCQ41544474-3682164E-9DE4-4731-9D9A-A6DC04E5FFBAQ43764719-9020FB56-BCFC-4986-8C1A-3A8C228B4F78Q44111674-2CCF3C93-346A-4749-9F1D-6546B2A280B0Q44257246-F9C4800F-5883-4576-8965-6AB3FC8A30E1Q44760466-BD8A8A47-2318-4E1C-8B88-8E01203D4E02Q44779601-C596DCAB-5E6D-4888-83DE-DF83C20BABD3Q46750499-91145216-3C7E-4A40-89F2-4EFC7B792EFAQ48220228-722137CD-82D6-45B9-A4A0-6189BC94EA88Q58706528-C2F6B57A-384D-43AE-BBDD-26E79BD52CB8
P2860
Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Receptor-independent role of u ...... ascular wound healing in mice.
@ast
Receptor-independent role of u ...... ascular wound healing in mice.
@en
type
label
Receptor-independent role of u ...... ascular wound healing in mice.
@ast
Receptor-independent role of u ...... ascular wound healing in mice.
@en
prefLabel
Receptor-independent role of u ...... ascular wound healing in mice.
@ast
Receptor-independent role of u ...... ascular wound healing in mice.
@en
P2093
P2860
P356
P1476
Receptor-independent role of u ...... ascular wound healing in mice.
@en
P2093
J M Herbert
M Dewerchin
P Carmeliet
S Rosenberg
P2860
P304
P356
10.1083/JCB.140.1.233
P407
P577
1998-01-01T00:00:00Z